Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis

被引:18
作者
Chua, Terence C. [1 ]
Liauw, Winston [1 ]
Robertson, Greg [1 ]
Morris, David L. [1 ,3 ]
Chia, Whay-Kuang John [2 ]
Soo, Khee-Chee [2 ]
AlObaid, Abdulaziz [3 ]
Al-Mohaimeed, Khaled [3 ]
Morris, David L. [1 ,3 ]
机构
[1] Univ New S Wales, Dept Surg, St George Hosp, Kogarah, NSW 2217, Australia
[2] Natl Canc Ctr Singapore, Singapore, Singapore
[3] King Fahad Med City, Riyadh, Saudi Arabia
关键词
STAGE-III OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; CISPLATIN; PACLITAXEL;
D O I
10.1016/j.ygyno.2009.03.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:137 / 139
页数:3
相关论文
共 14 条
[1]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[2]  
[Anonymous], 1996, PERITONEAL CARCINOMA
[3]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[4]  
BEREDER JM, 2008, 6 WORKSH PER SURF ON
[5]   Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis [J].
Bristow, Robert E. ;
Puri, Isha ;
Chi, Dennis S. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :265-274
[6]   Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study [J].
Eisenkop, SM ;
Friedman, RL ;
Wang, HJ .
GYNECOLOGIC ONCOLOGY, 1998, 69 (02) :103-108
[7]   Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia [J].
Glehen, O ;
Mohamed, F ;
Gilly, FN .
LANCET ONCOLOGY, 2004, 5 (04) :219-228
[8]   Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group [J].
Markman, M ;
Bundy, BN ;
Alberts, DS ;
Fowler, JM ;
Clark-Pearson, DL ;
Carson, LF ;
Wadler, S ;
Sickel, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :1001-1007
[9]  
Markman M, 2009, GYNECOL ONCOL
[10]  
SPRATT JS, 1980, CANCER RES, V40, P256